Varicella Zoster Virus Antibodies (IgG, IgM)

There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Chicken Pox, Herpes Zoster, Shingles, VaricellaZoster Virus Antibody IgG

Varicella Zoster Virus

Also known as: Chicken Pox IgM, Herpes Zoster IgM, Shingles, VaricellaZoster Virus Antibody IgM

Varicella Zoster Virus

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through Quest Diagnostics. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 Quest Diagnostics laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Varicella Zoster Virus Antibodies (IgG, IgM) panel contains 2 tests with 2 biomarkers.

Brief Description: The Varicella Zoster Virus IgG IgM Antibodies Panel is used to assess exposure to the varicella-zoster virus, which causes both chickenpox and shingles. By evaluating the presence and levels of specific antibodies, this panel aids in diagnosing current infections, determining immunity, and guiding vaccination decisions.

Please Note: Varicella-Zoster Virus Antibody IgG #4439 reliably measures immunity due to previous infection but may not be sensitive enough to detect antibodies induced by vaccination. Thus, a negative result in a vaccinated individual does not necessarily indicate susceptibility to VZV infection. A more sensitive test for vaccination-induced immunity is Varicella Zoster Virus Antibody Immunity Screen, ACIF #14505.

Collection Method: Blood Draw

Specimen Type: Serum

Test Preparation: No preparation required

Reasons Why the Varicella Zoster Virus Antibodies Panel May Be Ordered

Healthcare providers may order this panel for individuals presenting symptoms suggestive of a varicella-zoster virus infection, those uncertain about their immunity status, or as part of pre-vaccination screening. It's particularly relevant in clinical scenarios involving pregnancy, potential exposure to the virus, or before initiating immunosuppressive therapy.

What does the Panel Test For

Clinical Implications

The Varicella Zoster Virus IgG IgM Antibodies Panel is pivotal for:

  • Diagnosing Active Infections: Confirming or ruling out the presence of an active varicella-zoster virus infection.
  • Assessing Immunity: Determining whether an individual has immunity to the virus, either from past infection or vaccination.
  • Guiding Treatment and Prevention: Informing clinical decisions regarding the need for vaccination or other preventive measures.

Utilization in Clinical Practice

Results from this panel enable healthcare professionals to:

  • Diagnose varicella (chickenpox) or herpes zoster (shingles) infections accurately.
  • Make informed decisions about the care and management of individuals at risk of or showing symptoms of VZV infections.
  • Advise on vaccination or other preventive strategies based on determined immunity.

By offering a comprehensive look at an individual's immune response to the varicella-zoster virus, the Varicella Zoster Virus IgG IgM Antibodies Panel stands as an essential component of modern infectious disease diagnostics, prevention, and management strategies.

We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.

Customer Reviews